NEW YORK (GenomeWeb News) – Celera Genomics today said it has received $900,000 from the US National Institutes of Health to develop and commercialize an in vitro diagnostic for detect the A/H5 influenza virus.
 
Celera said it plans to develop the test using the primer, probe set, and protocols used by US Health and Human Services' Centers for Disease Control and Prevention, whose IP was recently cleared by the US Food and Drug Administration.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.